Utah Medical Products Inc.

05/04/2026 | Press release | Distributed by Public on 05/04/2026 13:09

Proxy Results (Form 8-K)

ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

On May 1, 2026 at the Company's annual meeting of stockholders, stockholders approved, did not approve or indicated their preference on the following matters submitted to them for consideration:

Elected Ernst G. Hoyer as a director of the Company:

For 1,330,333Withheld1,070,640Broker Non-Votes 372,329

Elected James H. Beeson as a director of the Company:

For 1,708,941Withheld 692,032Broker Non-Votes372,329

Ratified the selection of Haynie & Co. as the Company's independent public accounting firm for the year ended December 31, 2026:

For 2,753,278Against16,273Abstentions 3,751

Approved, on an advisory basis, the compensation paid to UTMD's named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion:

For 2,354,919Against 38,451Abstentions 7,603 Broker Non-Votes 372,329

The Company will continue to include annual advisory stockholder votes on executive compensation in its proxy materials. Annual advisory stockholder votes will be held until at least the next required advisory vote on frequency of stockholder votes on the compensation of executives.

Utah Medical Products Inc. published this content on May 04, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on May 04, 2026 at 19:09 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]